Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Shaughnessy

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Dermatologic Clinics|November 21, 2022
Melanoma classification and management in the era of molecular medicineSarem Rashid, Michael Shaughnessy, Hensin Tsao
The Journal of Investigative Dermatology|August 20, 2019
Classifying Melanoma by TERT Promoter Mutational StatusMichael Shaughnessy, Ching-Ni Njauw, Mykyta Artomov, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 29, 2026
Safety and Efficacy of a Multi-use Neurotoxin Protocol in Academic SettingsMichael Shaughnessy, Alexandra White, Elias Kean, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 27, 2024
Sex Influences Outcomes in Basal Cell CarcinomaMichael Shaughnessy, Fadi Murad, Frederick C Morgan, et al.
JID Innovations : Skin Science From Molecules to Population Health|November 30, 2023
Mendelian Randomization Analysis reveals Inverse Genetic Risks between Skin Cancers and VitiligoSarem Rashid, Ivan Molotkov, Nikolai Klebanov, et al.
Journal of the American Academy of Dermatology|October 23, 2024
Lentigo Maligna Part I: Epidemiology, Risk Factors, and DiagnosisSameer Gupta, Michael Shaughnessy, Sarem Rashid, et al.
International Journal of Oncology|September 24, 2019
Selective uveal melanoma inhibition with calcium channel blockadeMichael Shaughnessy, Grace Lamuraglia, Nikolai Klebanov, et al.
Journal of the American Academy of Dermatology|October 24, 2024
Lentigo Maligna Part II: ManagementSameer Gupta, Michael Shaughnessy, Sarem Rashid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2018
Drug Use and Postoperative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-analysisRyan Hall, Michael Shaughnessy, Griffin Boll, et al.
International Journal of Dermatology|January 11, 2023
Successful rechallenge with pembrolizumab after case of progressive immunotherapy-related mucocutaneous eruption (PIRME), a Stevens-Johnson syndrome-like reactionConnie R Shi, Michael Shaughnessy, Kartik Sehgal, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Dermatologic Clinics|November 21, 2022
Melanoma classification and management in the era of molecular medicineSarem Rashid, Michael Shaughnessy, Hensin Tsao
The Journal of Investigative Dermatology|August 20, 2019
Classifying Melanoma by TERT Promoter Mutational StatusMichael Shaughnessy, Ching-Ni Njauw, Mykyta Artomov, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 29, 2026
Safety and Efficacy of a Multi-use Neurotoxin Protocol in Academic SettingsMichael Shaughnessy, Alexandra White, Elias Kean, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 27, 2024
Sex Influences Outcomes in Basal Cell CarcinomaMichael Shaughnessy, Fadi Murad, Frederick C Morgan, et al.
JID Innovations : Skin Science From Molecules to Population Health|November 30, 2023
Mendelian Randomization Analysis reveals Inverse Genetic Risks between Skin Cancers and VitiligoSarem Rashid, Ivan Molotkov, Nikolai Klebanov, et al.
Journal of the American Academy of Dermatology|October 23, 2024
Lentigo Maligna Part I: Epidemiology, Risk Factors, and DiagnosisSameer Gupta, Michael Shaughnessy, Sarem Rashid, et al.
International Journal of Oncology|September 24, 2019
Selective uveal melanoma inhibition with calcium channel blockadeMichael Shaughnessy, Grace Lamuraglia, Nikolai Klebanov, et al.
Journal of the American Academy of Dermatology|October 24, 2024
Lentigo Maligna Part II: ManagementSameer Gupta, Michael Shaughnessy, Sarem Rashid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2018
Drug Use and Postoperative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-analysisRyan Hall, Michael Shaughnessy, Griffin Boll, et al.
International Journal of Dermatology|January 11, 2023
Successful rechallenge with pembrolizumab after case of progressive immunotherapy-related mucocutaneous eruption (PIRME), a Stevens-Johnson syndrome-like reactionConnie R Shi, Michael Shaughnessy, Kartik Sehgal, et al.
Pageof 2